ID: ALA1241017

Max Phase: Preclinical

Molecular Formula: C123H183N27O27

Molecular Weight: 2471.98

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H]1NC(=O)[C@H](CCCCNC(=O)CCCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](N)CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CCCCNC(=O)CCCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](N)CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CCCCNC(=O)CCCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](N)CCCCN)NC1=O

Standard InChI:  InChI=1S/C123H183N27O27/c1-76-109(163)145-95(29-14-23-62-131-104(158)32-8-5-20-65-134-116(170)98(68-80-36-48-86(152)49-37-80)149-122(176)101(71-83-42-54-89(155)55-43-83)143-107(161)74-137-113(167)92(128)26-11-17-59-125)119(173)140-78(3)111(165)147-96(30-15-24-63-132-105(159)33-9-6-21-66-135-117(171)99(69-81-38-50-87(153)51-39-81)150-123(177)102(72-84-44-56-90(156)57-45-84)144-108(162)75-138-114(168)93(129)27-12-18-60-126)120(174)141-77(2)110(164)146-94(118(172)139-76)28-13-22-61-130-103(157)31-7-4-19-64-133-115(169)97(67-79-34-46-85(151)47-35-79)148-121(175)100(70-82-40-52-88(154)53-41-82)142-106(160)73-136-112(166)91(127)25-10-16-58-124/h34-57,76-78,91-102,151-156H,4-33,58-75,124-129H2,1-3H3,(H,130,157)(H,131,158)(H,132,159)(H,133,169)(H,134,170)(H,135,171)(H,136,166)(H,137,167)(H,138,168)(H,139,172)(H,140,173)(H,141,174)(H,142,160)(H,143,161)(H,144,162)(H,145,163)(H,146,164)(H,147,165)(H,148,175)(H,149,176)(H,150,177)/t76-,77-,78-,91+,92+,93+,94+,95+,96+,97+,98+,99+,100+,101+,102+/m1/s1

Standard InChI Key:  IJZLPDMLJGSJCC-GTBINUOFSA-N

Associated Targets(Human)

Tumor necrosis factor receptor superfamily member 5 9 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tumor necrosis factor receptor R1 157 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

TRAIL receptor-1 4 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tumor necrosis factor receptor superfamily member 1B 1 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tumor necrosis factor receptor superfamily member 3 1 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tumor necrosis factor receptor superfamily member EDAR 1 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

BL-41 110 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tumor necrosis factor receptor superfamily member 17 1 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A20 109 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 2471.98Molecular Weight (Monoisotopic): 2470.3777AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Fournel S, Wieckowski S, Sun W, Trouche N, Dumortier H, Bianco A, Chaloin O, Habib M, Peter JC, Schneider P, Vray B, Toes RE, Offringa R, Melief CJ, Hoebeke J, Guichard G..  (2005)  C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L.,  (7): [PMID:16370373] [10.1038/nchembio746]

Source